Acute Spotted Fever Rickettsiosis among Febrile Patients, Cameroon

Emerging Infectious Diseases

Volumn 10, Issue 3, 2004, Pages 432-437

  Ndip, Lucy M ^a   Bouyer, Donald H ^b   Travassos Da Rosa, Amelia P A ^b   Titanji, V P K ^a   Tesh, Robert B ^b   Walker, David H ^b  

^a UNIVERSITY OF BUEA   (Cameroon)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; OUTER MEMBRANE PROTEIN; OUTER MEMBRANE PROTEIN A; OUTER MEMBRANE PROTEIN B; UNCLASSIFIED DRUG;

ACUTE DISEASE; ADULT; ALPHA VIRUS; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARBOVIRUS; ARTICLE; BLOOD SAMPLING; CAMEROON; CHIKUNGUNYA ALPHAVIRUS; CHILD; ENDEMIC DISEASE; FEMALE; FEVER; FLAVIVIRUS; HEMAGGLUTINATION INHIBITION; HUMAN; IMMUNOBLOTTING; IMMUNOFLUORESCENCE TEST; MAJOR CLINICAL STUDY; MALARIA; MALE; NONHUMAN; PARASITE VECTOR; PREVALENCE; RICKETTSIA AFRICAE; RICKETTSIOSIS; TICK BITE; TYPHOID FEVER;

EID: 1542377354     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid1003.020713     Document Type: Article

References (37)

1. Adesina OA, Adelola HA. Ecological distribution of chikungunya hemagglutination inhibition antibodies in humans and domestic animals in Nigeria. Trop Geogr Med 1991;43:271-5.
2. Thonnon J, Spiegel A, Diallo M, Fontenille D. Chikungunya outbreak in Senegal in 1996 and 1997. Bull Soc Pathol Exot 1999;2:79-82.
3. Nakounne E, Selekon B, Morvan J. Microbiological surveillance: viral hemorrhagic fever in Central African Republic: current serological data in man. Bull Soc Pathol Exot 2000;93:430-7.
4. Eisenhut M, Schwarz TF, Hegenscheid B. Seroprevalence of dengue, chikungunya and Sindbis virus infections in German aid workers. Infection 1999;27:82-5.
5. Shroyer DA. Aedes albopictus and arboviruses: a concise review of the literature. J Am Mosq Control Assoc 1986;2:424-8.
6. Fontenille D, Toto JC. Aedes (Stegomyia) albopictus (Skuse), a potential new dengue vector in southern Cameroon. Emerg Infect Dis 2001;7:1066-7.
7. Centers for Disease Control and Prevention. CDC dengue fever home page. [Date accessed June 2002]. Available from: www.cdc.gov/nci-dod/dvbid/dengue/index.htm
8. World Health Organization. Yellow fever. WHO/EPI/GEN/98.11. Geneva: The Organization; 1998.
9. Nathan N, Barry M, Van Herp N, Zeller H. Shortage of vaccines during a yellow fever outbreak in Guinea. Lancet 2001;358:2129-30.
10. Kelly PJ, Beati L, Mason PR, Matthewman LA, Roux V, Raoult D. Rickettsia africae sp. nov., the etiological agent of African tick bite fever. Int J Syst Bacteriol 1996;46:611-4.
11. Raoult D, Fournier PE, Fenollar F, Jensenius M, Prioe T, De Pina J, et al. Rickettsia africae, a tick-bome pathogen in travelers to sub-Saharan Africa. N Engl J Med 2001;334:1504-10.
12. Jensenius M, Hassle G, Henriksen AZ, Vene S, Raoult D, Bruu AL, et al. African tick-bite fever imported into Norway: presentation of 8 cases. Scand J Infect Dis 1999;31:131-3.
13. Kelly PJ, Matthewman LA, Beati L. African tick-bite fever-a new spotted group rickettsiosis under an old name. Lancet 1992;340:982-3.
14. Dupont HT, Brouqui P, Faugere B, Raoult D. Prevalence of antibodies to Coxiella burnetii, Rickettsia conorii, and Rickettsia typhi in seven African countries. Clin Infect Dis 1995;21:1126-33.
15. Gonzales JP, Fiset P, George AJ, Saluzzo JR, Wisseman Jr. Approche serologique sur l'incidence des rickettsioses en Republique Centrafricaine. Bull Soc Pathol Exot 1985;78:153-6.
16. Maurice Y, Femagut R, Gerome R. Contribution a l'etude des rickettsioses du Nord Cameroun enquete epidemiologique. Rev Elev Med Vet Pays Trop 1968;21:341-9.
17. Le Noc P, Rickenbach P, Le Noc D. Enquete serologique sur les rickettsioses animals au Cameroun. Bull Soc Pathol Exot Filiales 1977;4:402-21.
18. Zavala-Velazquez JE, Ruiz-Sosa J, Vado-Solis I, Billings AN, Walker DH. Serologic study of the prevalence of rickettsiosis in Yucatan: evidence for a prevalent spotted fever group rickettsiosis. Am J Trop Med Hyg 1999;61:405-8.
19. Hanson BA, Wisseman Jr CL, Waddell A, Silverman DJ. Some characteristics of heavy and light bands of Rickettsia prowazekii on renografin gradients. Infect Immun 1981;34:596-604.
20. Chen, S-M, Cullman, LC, Walker, DH. Western immunoblotting analysis of the antibody responses of patients with human monocytotropic ehrlichiosis to different strains of Ehrlichia chaffeensis and Ehrlichia canis. Clin Diagn Lab Immunol 1997;4:731-5.
21. Clarke DH, Casals J. Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses. Am J Trop Med Hyg 1958;7:561-73.
22. Fulton F, Dumbell KR. The serological comparison of strains of influenza virus. J Gen Microbiol 1946;3:97-111.
23. Kelly PJ, Mason PR, Mathewman LL, Raoult D. Seroepidemiology of spotted fever group rickettsial infections in humans in Zimbabwe. J Trop Med Hyg 1991;94:304-9.
24. Redus MA, Parker RA, McDade JE. Prevalence and distribution of spotted fever and typhus infections in Sierra Leone and Ivory Coast. Int J Zoonoses 1986;13:104-11.
25. Botros BA, Soliman AK, Darwish M, El Said S, Morrill JC, Ksiazek TG. Seroprevalence of murine typhus and fièvre boutonneuse in certain human populations in Egypt. J Trop Med Hyg 1989;92:373-8.
26. Sarov B, Galil A, Sikuler E, Yagupsky P, Saah A, Gilad A, et al. Prospective study on symptomatic versus asymptomatic infections and serological response to spotted fever group rickettsiae in two rural sites in the Negev (southern Israel). Ann N Y Acad Sci 1990;590:243-5.
27. Radulovic S, Walker DH, Weiss K, Dzelailija B, Morovic M. Prevalence of antibodies to spotted group rickettsiae along the eastern coast of the Adriatic Sea. J Clin Microbiol 1993;31:2225-7.
28. Jensenius M, Fournier P-E, Sirkka V, Hoel T, Hasle G, Henriksen AZ, et al. African tick bite fever in travelers to rural sub-equatorial Africa. Clin Infect Dis 2003;36:1411-7.
29. Walker DH. The role of host factors in severity of spotted fever and typhus rickettsiosis. Ann N Y Acad Sci 1990;590:10-9.
30. Walker DH, Hawkins HK, Hudson P. Fulminant Rocky Mountain spotted fever: its pathologic characteristics associated with glucose-6-phosphate dehydrogenase deficiency. Arch Pathol Lab Med 1983;107:121-5.
31. Topping NH. Experimental Rocky Mountain spotted fever and endemic typhus treated with prontosil or sulfapyridine. Public Health Rep 1939;54:1143-7.
32. Ruiz BR, Herrero Herrero JI. Deleterious effect of trimethoprim-sulfamethoxazole in Mediterranean spotted fever. Antimicrob Agents Chemother 1992;36:1342-3.
33. Salim AR, Porterfield JS. Serological survey on arbovirus antibodies in the Sudan. Trans R Soc Trop Med Hyg 1973;67:206-10.
34. Powers AM, Brault AC, Tesh RB, Weaver SC. Re-emergence of chikungunya and o'nyong-nyong viruses: evidence for distinct geographical lineages and distant evolutionary relationships. J Gen Virol 2000;81:471-9.
35. Jupp PG, McIntosh BM. Chikungunya virus disease. In: Monath P, editor. The arboviruses: epidemiology and ecology. Boca Raton (FL): CRC press; 1988. p. 137-57.
36. Diallo M, Thonnon J, Traore-Lamizana M, Fontenille D. Vectors of chikungunya in Senegal: current data and transmission cycles. Am J Trop Med Hyg 1999;60:281-6.
37. Carey DE. Chikungunya and dengue: a case of mistaken identify? J Hist Med Allied Sci 1971;26:243-62.